Parcourir par auteur "Vyzantiadis, T. A."
Voici les éléments 1-2 de 2
-
Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment
Speletas, M.; Vyzantiadis, T. A.; Kalala, F.; Plastiras, D.; Kokoviadou, K.; Antoniadis, A.; Korantzis, I. (2008)In this report we describe a patient suffering from chronic myeloid leukemia (CML), who was treated for 4.5 years with imatinib and developed pneumonia caused by two Candida species, i.e., C. krusei and C. glabrata. The ... -
Polyphasic Identification and Susceptibility to Seven Antifungals of 102 Aspergillus Isolates Recovered from Immunocompromised Hosts in Greece
Arabatzis, M.; Kambouris, M.; Kyprianou, M.; Chrysaki, A.; Foustoukou, M.; Kanellopoulou, M.; Kondyli, L.; Kouppari, G.; Koutsia-Karouzou, C.; Lebessi, E.; Pangalis, A.; Petinaki, E.; Stathi, A.; Trikka-Graphakos, E.; Vartzioti, E.; Vogiatzi, A.; Vyzantiadis, T. A.; Zerva, L.; Velegraki, A. (2011)In this study, the first such study in Greece, we used polyphasic identification combined with antifungal susceptibility study to analyze Aspergillus clinical isolates comprising 102 common and rare members of sections ...